Výsledky vyhledávání

AZD3759 enhances radiation effects in non-small-cell lung cancer by a synergistic blockade of epidermal growth factor receptor and Janus kinase-1

Autor: Ruing Zhao, Shenglin Ma, Qinghua Deng, Ke Zhang, Yanjiao Mao, Qingqing Yu, Wei Yin

Publikováno v: Bioengineered, Vol 13, Iss 1, Pp 331-344 (2022)
Bioengineered
article-version (VoR) Version of Record

AZD3759 is a novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) on the basis of gefitinib and has been proven to enter the central nervous system. Although the promising antitumor effects of AZD3759 on non-small cell lung c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a02b27a34b16729fbec81e6277da154c
https://doaj.org/article/6349d74c4c214d8f8b068e0be0c62853

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání